Lung cancer is a challenging disease to diagnose and treat, and is the most common cause of cancer death in both men and women worldwide. Five year survival rates remain poor at 9.0%, and on a global basis, the 2012 statistics suggest that lung cancer was responsible for 1.59 million deaths. A particular difficulty is that most lung cancers are diagnosed at a late stage, with about 75% of patients having advanced disease at the time of diagnosis. Identification of patients with lung cancer at an earlier stage is therefore vital if outcomes are to be improved. CT screening can identify possible cancerous nodules in the lung, but biopsy and histology, in which a tissue sample is examined under a microscope, is then required for diagnosis. The standard procedure to extract the tissue sample is trans-thoracic biopsy, in which a needle is inserted through the chest wall, typically under CT image guidance. This provides good diagnostic results, but is associated with complications, especially pneumothoraces (collapsed lung) which occurs in 15% of cases. More recently, technical advances have allowed biopsy to be performed through a bronchoscope, reducing the risk of complications and allowing the procedure to be performed during routine examination sessions. However, success is highly operator dependent and for remote, small nodules, the diagnostic rate (the yield) is poor. This is due to a number of factors, including the complexity of the bronchial tree, patient motion due to breathing (particularly at distal segments), poor ergonomics, and the large diameter of bronchoscopes prohibiting access beyond fourth generation bronchial segments (the fourth level of 'splitting' in the bronchial tree). The purpose of the REBOT project is to develop a robot-guided endobronchial probe that will allow access to the deepest reaches of the lung. It will be introduced through a working channel of a bronchoscope, making it highly compatible with current procedures. The probe will have integrated optical coherence tomography (OCT) and fluorescence imaging to allow multi-modal visualisation of the morphological and cellular details of the airways. Optical coherence tomography will provide 3D images to a depth of 1-2 mm into the tissue, while fluorescence imaging will provide high resolution surface imaging. These real-time imaging techniques will be used to help navigate the probe to the correct location for extraction of the biopsy tissue sample, increasing the chances of a successful diagnosis.

Bringing advanced computer vision to edge devices such as robots, consumer electronics, or sensor networks is challenging due to the constraints of power, size and communication bandwidth under which they often operate. We propose vertically integrated research into the paradigm of on-sensor computer vision, where sensing and processing are unified into single chip which produces abstract, information-rich output rather than images. We aim to demonstrate that on-sensor computer vision can be much more powerful and general than seen in previous research, and that the correct hardware design, software framework and algorithm choices permit switchable or even simultaneous computation of a broad set of vision competences (such as motion estimation, segmentation and scene classification) on a single device. We propose to work on the design of on-sensor computer vision systems through a programme of work from pixel-processing architecture design and microelectronic hardware implementation, through software platform development, to unified algorithm design and experimentation to determine how to use this hardware in a full application. This will enable camera devices that not only capture images, but have a powerful built-in vision capability to understand what they are looking at, and ultimately can go from light to decision on a single sensor/processor chip, with unprecedented speed, low power consumption and small footprint. We hope to open up a new class of edge applications where cameras can be much more efficient and independent, or for smart cameras to be used in ways never previously considered.

The current 'gold standard' for diagnosis and grading of many diseases (including most solid tumours) is largely based on an expert histopathologist's visual microscopic assessment of an extremely thin (only a few micrometers thick) section of the suspicious tissue specimen glued to a glass slide. This practice has remained more or less the same for several decades, and results in subjective and variable diagnosis. However, the recent uptake of digital slide scanners by some diagnostic pathology laboratories in the UK marks a new revolution in pathology practice in the NHS trusts, with our local NHS trust being the first one in the country to use digitally scanned images of tissue slides for routine diagnostics. The digital slide scanner produces a multi-gigapixel whole-slide image (WSI) for each histology slide, with each image containing rich information about tens of thousands of different kinds of cells and their spatial relationships with each other. This project aims to introduce a novel paradigm for analytics and computerised profiling of tissue microenvironment. We will develop sophisticated tools for image analytics in order to reveal spatial trends and patterns associated with disease sub-groups (for example, patient groups whose cancer is likely to advance more aggressively) and deploy those tools for clinical validation at our local NHS trust. This will be made possible by further advancing recent developments made in our group, such as those allowing us to recognise individual cells of different kinds in the WSIs consequently enabling us to paint a colourful picture of the tissue microenvironment which we term as the 'histology landscape'. Understanding and analysing the tissue microenvironment is not only crucial to assessing the grade and aggressiveness of disease and for predicting its course, it can also help us better understand how genomic alterations manifest themselves as structural changes in the tissue microenvironment. We will develop tools and techniques to extract patterns and trends found in the spatial structure and the 'social' interplay of different cells or colonies of cells found in the complex histology landscapes. Our goal is to establish the effective use of image analytics for understanding the histology landscape in a quantitative and systematic manner, facilitating the discovery of image-based markers of disease progression and survival that are intuitive, biologically meaningful, and clinically relevant - eventually leading to optimal selection of treatment option(s) customised to individual patients. This project will analyse real image data and associated clinical and genomics data from patient cohorts for colorectal cancer as a case study. The research staff on this project will work closely with clinical collaborators to ensure the biological significance and clinical relevance of spatial trends and patterns found in the data. In collaboration with our industrial partner Intel, we will test and demonstrate the effectiveness of our methods in a clinical setting potentially leading to better healthcare provision for patients and potential cost savings for the NHS.

There are tremendous demands for advanced statistical methodology to make scientific sense of the deluge of data emerging from the data revolution of the 21st Century. Huge challenges in modelling, computation, and statistical algorithms have been created by diverse and important questions in virtually every area of human activity. CoSInES will create a step change in the use of principled statistical methodology, motivated by and feeding into these challenges. Much of our research will develop and study generic methods with applicability in a wide-range of applications. We will study high-dimensional statistical algorithms whose performance scales well to high-dimensions and to big data sets. We will develop statistical theory to understand new complex models stimulated from applications. We will produce methodology tailored to specific computational hardware. We will study the statistical and algorithmic effects of mis-match between data and models. We shall also build methodology for statistical inference where privacy constraints mean that the data cannot be directly accessed. CoSInES willl also focus on two major application domains which will form stimulating and challenging motivation for our research: Data-centric engineering, and Defence and Security. To maximise the impact and speed of translation of our research in these areas, we will closely partner the Alan Turing Institute which is running large programmes in these areas funded respectively by the Lloyd's Register Foundation and GCHQ. Data is providing a disruptive transformation that is revolutionising the engineering professions with previously unimagined ways of designing, manufacturing, operating and maintaining engineering assets all the way through to their decommissioning. The Data centric engineering programme (DCE) at the Alan Turing Institute is leading in the design and operation of the worlds very first pedestrian bridge to be opened and operated in a major international city that will be completely 3-D printed. Fibre-optic sensors embedded in the structure will provide continuous streams of data measuring the main structural properties of the bridge. Unique opportunities to monitor and control the bridge via "digital twins" are being developed by DCE and this is presenting enormous challenges to existing applied mathematical and statistical modelling of these complex structures where even the bulk material properties are unknown and certainly stochastic in their values. A new generation of numerical inferential methods are being demanded to support this progress. Within the Defence and Security domain, there are many statistical challenges emerging from the need to process and communicate big and complex data sets, for example within the area of cyber-security. The virtual world has emerged as a dominant global marketplace within which the majority of organisations operate. This has motivated nefarious actors - from "bedroom hackers" to state-sponsored terrorists - to operate in this environment to further their economic or political ambitions. To counter this threat, it is necessary to produce a complete statistical representation of the environment, in the presence of missing data, significant temporal change, and an adversary willing to manipulate socio and virtual systems in order to achieve their goals. As a second example, to counter the threat of global terrorism, it is necessary for law-enforcement agencies within the UK to share data, whilst rigorously applying data protection laws to maintain individuals' privacy. It is therefore necessary to have mathematical guarantees over such data sharing arrangements, and to formulate statistical methodologies for the "penetration testing" of anonymised data.

Vascular disease is the most common precursor to ischaemic heart disease and stroke, which are two of the leading causes of death worldwide. Advances in endovascular intervention in recent years have transformed patient survival rates and post-surgical quality of life. Compared to open surgery, it has the advantages of faster recovery, reduced need for general anaesthesia, reduced blood loss and significantly lower mortality. However, endovascular intervention involves complex manoeuvring of pre-shaped catheters to reach target areas in the vasculature. Some endovascular tasks can be challenging for even highly-skilled operators. The use of robot assisted endovascular intervention aims to address some of these difficulties, with the added benefit of allowing the operator to remotely control and manipulate devices, thus avoiding exposure to X-ray radiation. The purpose of this work is to develop a new robot-assisted endovascular platform, incorporating novel device designs with improved human-robot control. It builds on our strong partnership with industry aiming to develop the next generation robots that are safe, effective, and accessible to general NHS populations.